Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
11–20 of 123 posts
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#12Not sure they've been doing proper studies and such because they're so slammed, but it seems they've been trying it in Italy and... maybe it helps some, but doesn't seem like it works miracles.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#13I wish the current U.S. administration hadn't tried to turn this into a partisan issue.
The press did.
The mainstream US media has become a one-sided partisan cheerleading squad for the Democrats, and most Americans are sick of it. We'll see how that works out in November.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#14Seems relevant: https://twitter.com/SquawkCNBC/status/1245669685267439616 Not sure they've been doing proper studies and such because they're so slammed, but it seems they've been trying it in Italy and... maybe it helps some, but doesn't seem like it works miracles.
A doctor in NY has treated with that combination and is up to almost 700 COVID-19 patients without one dying _or needing a ventilator_.
Some relevant quotes:
>Dr. Zelenko said the whole treatment costs only $20 over a period of 5 days with 100% success. He defines success as “Not to die.” Dr. Zelenko first posted his Facebook video message last week calling on President Trump to “advise the country that they should be taking this medication.”
>There are many other success stories about hydroxychloroquine across the country. Last week, Dr. William Grace, an oncologist at Lenox Hill Hospital in New York City, said they’ve not had a single death in their hospital because of hydroxychloroquine. “Thanks to hydroxychloroquine, we have not had a death in our hospital,’ Dr. Grace said.
From:
https://techstartups.com/2020/03/28/dr-vladimir-zelenko-now-...
When people are dying in large numbers, sometimes "anecdotal evidence" (especially with large samples) is plenty.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#15Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#16I wish the current U.S. administration hadn't tried to turn this into a partisan issue.
Its much more enticing for Big Pharma to sell new patented solutions, so they will pay their PR mouthpieces (MSM) to "be cautious" of anything that doesn't achieve that end goal.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#17“ Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.”
So hate to ask this, can you explain this for non-medical spectators? Specifically what TTCR and is "absorption of pneumonia" a good thing (e.g. the body has absorbed the pneumonia and therefore it has gone away) or a bad thing (e.g. the body has absorbed the pneumonia and therefore has "collected" more)? From Paper: TTCR: Time to clinical recovery
I will assume that 'absorption' in this sense refers to the fluid. It's a good thing when this happens, because that that area of the lung can be accessed by air again.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#18“ Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.”
So hate to ask this, can you explain this for non-medical spectators? Specifically what TTCR and is "absorption of pneumonia" a good thing (e.g. the body has absorbed the pneumonia and therefore it has gone away) or a bad thing (e.g. the body has absorbed the pneumonia and therefore has "collected" more)? From Paper: TTCR: Time to clinical recovery
edit: got downvoted, so adding link to only other "absorption of pneumonia" use that I could find: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344839/
edit2: I could also find some usage of "absorption of inflammation", again also all Chinese researchers.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#19It is very unfortunate that the media politicized this treatment in such a way that now everyone who dislikes Trump carries an initial bias against it.
Re: Efficacy of hydroxychloroquine in patients with Covid-19: a randomized trial
#20The sample size is 62 and the mortality rates are between 0% and 7% depending primarily on age and co-morbidities. I don't think we can draw any meaningful conclusions from this other than what we already know: seems worth looking into HCQ more.